Orris

Synopsis topic

Asking for Preferences
Please share more details so I can help you effectively:
  1. What is the topic? (e.g., a specific disease, drug, book, research paper, film, etc.)
  2. What type of synopsis do you need? (e.g., a medical topic summary, a story plot summary, an academic abstract, etc.)
  3. Who is the audience? (e.g., medical students, general public, researchers)
The more context you give me, the better I can tailor the synopsis for you.

For thesis ent

Asking for Preferences
To write your ENT thesis synopsis well, I need a few key details. Please type your answers:
  1. What is your exact thesis topic? (e.g., "Outcome of tympanoplasty in chronic otitis media mucosal type", "Role of BERA in sensorineural hearing loss", etc.)
  2. What level is this for? (MS/MD, MBBS dissertation, PhD)
  3. Any specific study design in mind? (e.g., prospective observational, retrospective, RCT)
  4. Institution/university format requirements? (word limit, specific sections required, etc.)
Please share these and I'll draft a complete synopsis for you.

Pg rhinitis

Asking for Preferences
Reading File
Finding Sources
Searching PubMed

allergic rhinitis comorbidities asthma sinusitis

Reading File
Searching PubMed

rhinitis sinusitis asthma unified airway comorbidity

Reading File
Reading File
Reading File
I have sufficient content now. Here is your complete PG (MS/MD) thesis synopsis on rhinitis with comorbidities:

THESIS SYNOPSIS

TITLE

"A Retrospective Study of the Pattern of Comorbidities (Bronchial Asthma and Chronic Rhinosinusitis) in Patients with Rhinitis Attending a Tertiary Care Centre"
(This title can be refined based on your institution's focus. Alternative titles are suggested at the end.)

INTRODUCTION

Rhinitis is one of the most prevalent chronic conditions affecting the upper airway, characterized by symptoms of nasal congestion, rhinorrhea, sneezing, and nasal pruritus. It is classified into allergic rhinitis (AR) and non-allergic rhinitis (NAR), with several subtypes including non-allergic rhinitis with eosinophilia syndrome (NARES), local allergic rhinitis (LAR), vasomotor rhinitis, and drug-induced rhinitis.
Allergic rhinitis represents a TH2-mediated immune response triggered by exposure to environmental allergens. It exerts a significant individual and societal burden — ranking 5th among all chronic diseases in the United States in terms of economic impact, with annual direct costs estimated at up to $5 billion. Patients with AR experience significantly decreased quality of life, impaired sleep, and reduced workplace productivity.
The concept of the "Unified Airway" — recognizing that the upper and lower respiratory tracts constitute a single functional unit sharing common mucosal lining, physiology, and inflammatory pathways — has gained widespread acceptance. Rhinitis is now recognized as a major risk factor and co-trigger for bronchial asthma. Studies consistently show that 20–50% of AR patients have co-existing asthma, and up to 80% of asthmatic patients report nasal symptoms. Similarly, the anatomical and mucosal continuity between the nose, sinuses, and nasopharynx makes rhinosinusitis a common and clinically significant comorbidity of rhinitis, as impaired mucociliary clearance and ostial obstruction precipitate sinus disease.
Despite this well-established relationship, there is limited retrospective data from tertiary ENT centres in India characterizing the prevalence, pattern, and severity of these comorbidities together in a rhinitis cohort. The present study is designed to address this gap.

AIM

To study the pattern of comorbidities — bronchial asthma and chronic rhinosinusitis — in patients diagnosed with rhinitis attending the ENT OPD of [Your Institution].

OBJECTIVES

  1. To determine the prevalence of rhinitis subtypes (allergic, non-allergic, NARES, LAR) among study patients.
  2. To assess the prevalence and severity of bronchial asthma as a comorbidity in rhinitis patients.
  3. To assess the prevalence and staging of chronic rhinosinusitis (with or without nasal polyposis) as a comorbidity.
  4. To correlate the type and severity of rhinitis with the type and severity of its comorbidities.
  5. To describe the demographic and clinical profile of the study population.

REVIEW OF LITERATURE

1. Classification of Rhinitis

The ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines classify AR as intermittent or persistent, and as mild or moderate-severe based on symptom frequency and impact on daily activities. Non-allergic rhinitis encompasses vasomotor rhinitis, NARES, drug-induced rhinitis, hormonal rhinitis, and local allergic rhinitis (LAR) — the last being a distinct phenotype where nasal-specific IgE is produced locally despite negative systemic allergy testing.

2. Pathophysiology

AR pathophysiology involves a two-phase response:
  • Sensitization phase: Allergen exposure activates APCs → TH2 differentiation → IgE production → IgE binds mast cells and basophils.
  • Clinical disease phase (early and late): Re-exposure causes mast cell degranulation → histamine, leukotrienes, prostaglandins → immediate symptoms. Subsequent cellular infiltration (eosinophils, basophils) perpetuates chronic inflammation and nasal hyperresponsiveness.
The priming phenomenon — whereby repeated allergen exposure progressively lowers the symptom threshold — is a key mechanism linking persistent rhinitis to downstream comorbidities (Cummings Otolaryngology, 7e).

3. Rhinitis and Asthma

The unified airway hypothesis postulates that inflammation in the upper airway potentiates lower airway disease via:
  • Postnasal drip triggering bronchial hyper-reactivity
  • Systemic cytokine spread (IL-4, IL-5, IL-13)
  • Loss of nasal conditioning (warming, humidification, filtration) of inspired air
  • Nasobronchial reflex
Multiple systematic reviews and the ARIA guidelines confirm that effective treatment of AR improves asthma control, and vice versa.

4. Rhinitis and Chronic Rhinosinusitis

Rhinitis and chronic rhinosinusitis (CRS) share overlapping TH2 eosinophilic inflammation pathways. Nasal mucosal edema in AR impairs sinus ostial drainage, promotes mucus stasis, and predisposes to bacterial colonization and CRS. CRS with nasal polyps (CRSwNP) is strongly associated with AR and NARES (eosinophilic phenotype). Recent biologics targeting IL-4Rα (dupilumab) and IL-5 show efficacy across the whole spectrum, further supporting shared pathobiology.

MATERIAL AND METHODS

Study Design

Retrospective observational study.

Study Setting

Department of ENT & Head-Neck Surgery, [Your Institution].

Study Period

[e.g., January 2020 – December 2023] (3 years).

Study Population

All patients diagnosed with rhinitis (allergic or non-allergic) who attended the ENT OPD during the study period.

Inclusion Criteria

  • Age ≥ 12 years
  • Diagnosed with rhinitis (AR or NAR) based on history, clinical examination, and relevant investigations
  • Adequate case records available

Exclusion Criteria

  • Patients with incomplete records
  • Patients with a known primary diagnosis of malignancy or immunodeficiency
  • Post-surgical cases where rhinitis may be secondary to structural abnormality alone

Sample Size

To be calculated based on expected prevalence of asthma comorbidity in rhinitis (~25–30%) at 95% confidence interval and 10% allowable error using the formula: n = Z²pq/d². (Expected n ≈ 73–96; exact calculation pending institutional data)

Data Collection

Data will be extracted from medical records, OPD files, and investigation reports. A structured proforma will record:
  • Demographic data (age, sex, occupation, residence)
  • Type and duration of rhinitis
  • ARIA severity classification
  • Results of skin prick test / serum IgE / nasal smear eosinophilia
  • Presence, type, and severity of asthma (GINA classification)
  • Presence and staging of chronic rhinosinusitis (CT — Lund-Mackay score)
  • Treatment received

Outcome Measures

  • Prevalence of comorbidities
  • Correlation between rhinitis type/severity and comorbidity severity

Statistical Analysis

Data will be entered in Microsoft Excel and analyzed using SPSS v.26 (or equivalent). Descriptive statistics (mean ± SD, frequencies, proportions) will be used for demographic data. Chi-square test and Fisher's exact test for categorical variables; unpaired t-test / Mann-Whitney U for continuous variables. Pearson's / Spearman's correlation for association between rhinitis severity and comorbidity scores. p < 0.05 will be considered statistically significant.

ETHICAL CONSIDERATIONS

The study will be conducted after approval from the Institutional Ethics Committee (IEC). As this is a retrospective study involving record review only, a waiver of informed consent may be sought per institutional policy. Patient confidentiality will be maintained throughout.

EXPECTED OUTCOMES

  1. A clear picture of the burden and pattern of rhinitis at a tertiary ENT centre.
  2. Quantification of the prevalence of asthma and CRS as comorbidities.
  3. Identification of rhinitis subtypes most strongly associated with specific comorbidities.
  4. Data that can guide integrated upper and lower airway management protocols.

REFERENCES (Key references — to be expanded)

  1. Fokkens W, Reitsma S. Unified Airway Disease: A Contemporary Review and Introduction. Otolaryngol Clin North Am. 2023;56(1). [PMID: 36266105]
  2. Bachert C, Luong AU, Gevaert P. The Unified Airway Hypothesis: Evidence From Anti-IL-5 Biologic Therapy. J Allergy Clin Immunol Pract. 2023;11(9). [PMID: 37207831]
  3. Bousquet J et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update. Allergy. 2008;63(Suppl 86):8–160.
  4. Naclerio RM. Allergic Rhinitis. N Engl J Med. 1991;325:860.
  5. Cummings Otolaryngology: Head and Neck Surgery, 7th Ed. Chapter 35 — Allergic Rhinitis. Flint PW et al., eds. Elsevier.
  6. De Corso E et al. Clinical Evidence of Type 2 Inflammation in Non-allergic Rhinitis with Eosinophilia Syndrome: a Systematic Review. Curr Allergy Asthma Rep. 2022. [PMID: 35141844]

ALTERNATIVE TITLE SUGGESTIONS

  1. "Prevalence of Bronchial Asthma and Chronic Rhinosinusitis as Comorbidities in Allergic Rhinitis: A Hospital-Based Retrospective Study"
  2. "Pattern of Upper and Lower Airway Comorbidities in Patients with Rhinitis: A Retrospective Analysis"
  3. "Unified Airway Disease: A Retrospective Study of Rhinitis and Its Association with Asthma and Chronic Rhinosinusitis"
Note: Replace bracketed placeholders ([Your Institution], study period, sample size) with your actual data. The synopsis follows the standard format used for MS ENT theses registered with NBE/university boards. Adjust section headings to match your university's proforma if needed.
This is a shared conversation. Sign in to Orris to start your own chat.